The Changing Epidemiology of Autism Spectrum Disorders
By K. Lyall, L. Croen, J. Daniels, M. Fallin, Christine Ladd-Acosta, Brian K Lee, B. Park, Nathaniel W. Snyder, Diana Schendel, H. Volk and 2 more. Annual Review of Public Health, 2016
902 citations recorded by the source corpus.
Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with lifelong impacts. Genetic and environmental factors contribute to ASD etiology, which remains incompletely understood. Significant advances in ASD epidemiology have been seen in the past decade. Current prevalence is estimated to be at least 1.5% in developed countries, with recent increases primarily among those without comorbid intellectual disability. Genetic studies have identified a number of rare de novo mutations, and gained footing in the areas of polygenic risk, epigenetics, polygenic risk, and gene x environment (GxE) interaction. Epidemiologic investigations focused on non-genetic factors have established advanced parental age and preterm birth as ASD risk factors, indicated that prenatal exposure to air pollution and short inter-pregnancy interval are potential risk factors, and suggest that further exploration of certain prenatal nutrients, metabolic conditions, and exposure to endocrine-disrupting chemicals is warranted. Future challenges and goals for ASD epidemiology are discussed.
Subfields: Cognitive Neuroscience, Genetics, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/65040948ceee6a4505fe4c5aa78925e192949f36
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cognitive Neuroscience
In Genetics
In Psychiatry and Mental health
Citations in the corpus
- Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. (2019, methodology): “reported: (1) CMHCs not confirmed with DSM/ICD criteria; (2) lifetime diagnoses of CMHCs,”